Physician profile
Mohamed Eid
NPI 1679185623
$1,064.44
in general payments reported to CMS, 2019-2025
13 companies · $557 in 2025
The $557 reported for 2025 was more than what 91% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $507 · 2025: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $681 · Education: $383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $681.44 |
| Education | $383.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $439.14 | 2024-2025 | Ensite, Jot Dx, Perclose Prostyle |
| Abiomed | $91.43 | 2024 | Impella |
| Heartflow, INC. | $85.89 | 2025 | |
| Medtronic, INC. | $72.81 | 2024-2025 | Cobalt Dr Mri Surescan |
| Edwards Lifesciences Corporation | $72.64 | 2024-2025 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $66.41 | 2024-2025 | General - Brady |
| E.R. Squibb & Sons, L.L.C. | $56.00 | 2025 | Camzyos |
| Cvrx, INC. | $51.18 | 2025 | Barostim Neo System |
| Kiniksa Pharmaceuticals International, Plc | $30.07 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $28.82 | 2025 | |
| Pfizer INC. | $26.13 | 2024 | |
| Alnylam Pharmaceuticals INC. | $25.04 | 2025 | Amvuttra |
| Inspire Medical Systems, INC. | $18.88 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohamed Eid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.